The Hematology-Oncology Fellowship Training Program at Washington University School of Medicine is designed to attract outstanding young physicians and train them for academic careers in the fields of hematology and oncology. The Fellowship Program offers intensive clinical and research training in hematology and oncology and is administered jointly by the Divisions and Medical Oncology in the Department of Medicine. The training faculty for the Divisions includes approximately 70 full-time academic investigators.
The University offers a flexible program that provides trainees with comprehensive exposure to the various disciplines of hematology and oncology and accommodates their specific interests. A balance is sought between providing a sound clinical understanding of hematologic and malignant diseases and providing the environment for creative research into significant problems.
Incoming fellows have the opportunity to choose between two tracks: the Clinical Research Track and the Laboratory Research Track. The first year for both the clinical and lab research fellows is identical. Approximately one-half of the trainees in the Fellowship Program enter each track.
Clinical Research Track
The second and third years are designed to allow clinical fellows to complete requirements necessary for double-boarding in hematology and oncology. Fellows are encouraged to do two or more continuity clinics to broaden their exposure to various oncologic subspecialties. When not on clinical rotations, fellows are given time to pursue scholarly activities including research protocol development and preparing articles for publication.
Laboratory Research Track
The second and third years are designed to give laboratory fellows two or more years of protected research time. Laboratory fellows are not required to do any further clinical rotations (unless seeking to double-board), but will have one half-day per week of clinic and occasional weekend calls.
The Clinical Hematology Research Career Development Program at Washington University (Hematology CDP) is a new initiative of the NIH Roadmap that will prepare trainees (Heme Scholars) to address complex clinical and translational research problems in non-malignant hematology. Scholars are expected to become independent researchers and assume leadership roles in non-malignant clinical hematology.
The Hematology CDP combines disease-specific and general clinical research teaching with a mentored clinical research project, over two or three years, for Scholars selected from an outstanding and diverse candidate pool. Scholars will be clinical or research Fellows, clinical or research Instructors, or recently appointed Assistant Professors.
For more information, please visit the Heme Scholars web site at http://hemescholars.im.wustl.edu/.